2014
DOI: 10.5653/cerm.2014.41.1.15
|View full text |Cite
|
Sign up to set email alerts
|

Amelioration of lipid abnormalities by vitamin therapy in women using oral contraceptives

Abstract: ObjectiveCombined oral contraceptives (COCs) have some adverse effects on the serum lipid profile. Because hyperlipidemia is one of the risk factors in cardiovascular diseases, lipid abnormalities should be evaluated in women consuming COCs. Vitamins E and C are known to have beneficial effects on serum lipid profiles. Therefore, in this study, we evaluated the effects of vitamins E and C on serum lipids in women using COCs.MethodsThe study compared changes in lipid parameters with and without vitamin therapy … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 29 publications
0
4
0
Order By: Relevance
“…4 Some research has reported a 22% rise in Low Density Lipoprotein (LDL) cholesterol among users of combined oral contraceptive (COC) without a concomitant increase in HDL resulting in a reduction of HDL/LDL ratio. 5 Furthermore prolonged use of oral contraceptives decreases glucose tolerance over time by increasing insulin resistance and decreasing beta cell function. 6,7 In another study, the injectable contraceptive; depot medroxyprogesterone acetate was reported to cause increases in LDL cholesterol levels and decreases in HDL cholesterol concentration.…”
Section: Introductionmentioning
confidence: 99%
“…4 Some research has reported a 22% rise in Low Density Lipoprotein (LDL) cholesterol among users of combined oral contraceptive (COC) without a concomitant increase in HDL resulting in a reduction of HDL/LDL ratio. 5 Furthermore prolonged use of oral contraceptives decreases glucose tolerance over time by increasing insulin resistance and decreasing beta cell function. 6,7 In another study, the injectable contraceptive; depot medroxyprogesterone acetate was reported to cause increases in LDL cholesterol levels and decreases in HDL cholesterol concentration.…”
Section: Introductionmentioning
confidence: 99%
“…However, given the differences in the formulations used in these studies-both qualitative and quantitative-their findings remain controversial, as does the potential association between the use of OCs and cardiovascular disease risks [150,151]. It is recognized that both vitamins C and E confer enhanced effects on the profiles of lipids and the impact of the use of COCs on serum lipids in women over 4 weeks has been investigated in one study [152]. Statistically significantly higher increases in the levels of LDL cholesterol and triglycerides and LDL were reported in COC users than non-users.…”
Section: Lipidemic Effects Of Oral Contraceptivementioning
confidence: 99%
“…8 Visto que a dislipidemia e alterações nos mecanismos de oxidação são um dos fatores de risco da DAC, a prevenção desses efeitos secundários é de extrema importância. Evidências experimentais e epidemiológicas sugeriram que algumas vitaminas antioxidantes, C e E, mostram-se eficientes na redução da dislipidemia e de danos oxidativos e assim diminuindo o risco cardiovascular [8][9][10][11][12][13][14][15] .…”
Section: Introductionunclassified